Neutrophil activator of matrix metalloproteinase-2 (NAM)

被引:0
|
作者
Ellen E. Rollo
Michelle Hymowitz
Cathleen E. Schmidt
Steve Montana
Hussein Foda
Stanley Zucker
机构
[1] Veterans Affairs Medical Center,Departments of Research and Medicine
[2] State University of New York at Stony Brook,School of Medicine
来源
关键词
Extracellular matrix; Matrix metalloproteinase (MMP); Metastasis; MMP activation; Neutrophil; Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
We have isolated a novel soluble factor(s), neutrophil activator of matrix metalloproteinases (NAM), secreted by unstimulated normal human peripheral blood neutrophils that causes the activation of cell secreted promatrix metalloproteinase-2 (proMMP-2). Partially purified preparations of NAM have been isolated from the conditioned media of neutrophils employing gelatin-Sepharose chromatography and differential membrane filter centrifugation. NAM activity, as assessed by exposing primary human umbilical vein endothelial cells (HUVEC) or HT1080 cells to NAM followed by gelatin zymography, was seen within one hour. Tissue inhibitor of metalloproteinase-2 (TIMP-2) and hydroxamic acid derived inhibitors of MMPs (CT1746 and BB94) abrogated the activation of proMMP-2 by NAM, while inhibitors of serine and cysteine proteases showed no effect. NAM also produced an increase in TIMP-2 binding to HUVEC and HT1080 cell surfaces that was inhibited by TIMP-2, CT1746, and BB94. Time-dependent increases in MT1-MMP protein and mRNA were seen following the addition of NAM to cells. These data support a role for NAM in cancer dissemination.
引用
收藏
页码:259 / 268
页数:9
相关论文
共 50 条
  • [1] Neutrophil activator of matrix metalloproteinase-2 (NAM)
    Rollo, Ellen E.
    Hymowitz, Michelle
    Schmidt, Cathleen E.
    Montana, Steve
    Foda, Hussein
    Zucker, Stanley
    CLINICAL & EXPERIMENTAL METASTASIS, 2006, 23 (5-6) : 259 - 268
  • [2] Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2
    Kimura, Kaoru
    Cheng, Xian Wu
    Nakamura, Kae
    Inoue, Aiko
    Hu, Lina
    Song, Haizhen
    Okumura, Kenji
    Iguchi, Akihisa
    Murohara, Toyoaki
    Kuzuya, Masafumi
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11) : 1096 - 1101
  • [3] Matrix metalloproteinase-2 in dentin matrix mineralization
    Satoyoshi, M
    Kawata, A
    Koizumi, T
    Inoue, K
    Itohara, S
    Teranaka, T
    Mikuni-Takagaki, Y
    JOURNAL OF ENDODONTICS, 2001, 27 (07) : 462 - 466
  • [4] Effects of valsartan on matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in atrial fibrillation patients
    裴晓阳
    潘莹
    颜雯
    胡雪松
    SouthChinaJournalofCardiology, 2010, 11 (01) : 15 - 19
  • [5] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [6] Expression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in oral squamous cell carcinomas
    Radhakrishnan, R.
    Shrestha, B.
    Bajracharya, D.
    ORAL ONCOLOGY, 2011, 47 : S84 - S84
  • [7] Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium
    Chung, HW
    Lee, JY
    Moon, HS
    Hur, SE
    Park, MH
    Wen, Y
    Polan, ML
    FERTILITY AND STERILITY, 2002, 78 (04) : 787 - 795
  • [8] ACTIVATION OF MATRIX METALLOPROTEINASE-3 (STROMELYSIN) AND MATRIX METALLOPROTEINASE-2 (GELATINASE) BY HUMAN NEUTROPHIL ELASTASE AND CATHEPSIN-G
    OKADA, Y
    NAKANISHI, I
    FEBS LETTERS, 1989, 249 (02) : 353 - 356
  • [9] Matrix metalloproteinase-9 and matrix metalloproteinase-2 in multiple sclerosis
    Benesova, Y.
    Beranek, M.
    Novotna, H.
    Stourac, P.
    Hladikova, M.
    Kadanka, Z.
    Vasku, A.
    Bednarik, J.
    JOURNAL OF NEUROLOGY, 2008, 255 : 114 - 114
  • [10] Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase
    Schwartz, JD
    Shamamian, P
    Monea, S
    Whiting, D
    Marcus, SG
    Galloway, AC
    Mignatti, P
    SURGERY, 1998, 124 (02) : 232 - 238